March 29, 2013
Takeda Pharmaceutical announced on March 27 that the company filed a new drug application (NDA) for a fixed-dose combination of its peptic ulcer treatment Takepron (lansoprazole) and low-dose aspirin with the Ministry of Health, Labor and Welfare (MHLW) on the...read more